Analyst Ratings for Medivation Inc (MDVN)

Updated: 2016-09-27



Many analysts weighed in on price targets for MDVN. The most optimistic analyst gave a price target of 82, implying potential capital gains of 0.69 percent. The most pessimistic analyst gave a price target of 64, which equates to a potential downside of -21.41 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Analysts have revised their earnings estimates downwards for this quarter, by about -1.32 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is 1.37 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 8.29 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 1 analysts that decreased their estimates. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 1 analysts made negative revisions to their fiscal year's estimates.

MDVN has a 52-week high of 81.48 and a 52-week low of 26.41. Today's price is 208.37 percent above the 52-week low, and 0.05 percent lower than its 52-week high. MDVN has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The MDVN value stock report compares MDVN to some of its peers using value stock charts. The stock has a market capitalization of $13.57 billion. MDVN will post this quarters earnings in -741 days, on 2016-11-03.